VAERS reports by lot

GSK DTaP/Tdap lot GA5Z5: VAERS reports

21 VAERS reports list lot GA5Z5 as a GSK DTaP/Tdap vaccine, received between 2019-01-07 and 2020-03-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
5%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1823%
General / Systemic (non-local)1621%
Injection-site / Local reaction1317%
Musculoskeletal1114%
Allergic / Anaphylactic45%
Respiratory45%
Gastrointestinal45%
Dermatological (non-injection-site)34%
Cardiac / Cardiovascular23%
Psychiatric / Neuropsychiatric23%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas5
Minnesota3
Washington3
Oklahoma1
Utah1
North Carolina1
Georgia1
Virginia1
Massachusetts1
Pennsylvania1
Wisconsin1
California1

Reports by month received

2019-011
2019-022
2019-035
2019-044
2019-052
2019-063
2019-081
2020-011
2020-032

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.